FMII
VNDA icon

Farmers & Merchants Investments Inc’s Vanda Pharmaceuticals VNDA Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-37
Closed -$244 – 1814
2023
Q2 		$244 Hold
37
– – ﹤0.01% 1709
2023
Q1 		$251 Hold
37
– – ﹤0.01% 1691
2022
Q4 		$273 Hold
37
– – ﹤0.01% 1711
2022
Q3 		$0 Buy
+37
New +$391 ﹤0.01% 1768

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Farmers & Merchants Investments Inc's VNDA Position: Q3 2023 in Review

Farmers & Merchants Investments Inc sold out of Vanda Pharmaceuticals (VNDA) in Q3 2023, closing a stake of 37 shares — an estimated $244 sold.

Farmers & Merchants Investments Inc first reported a position in VNDA in Q3 2022 and held it in 4 quarters. The position peaked at $273 in Q4 2022. 179 funds tracked by Wall St. Rank hold VNDA as of Q3 2023.

  • Farmers & Merchants Investments Inc reported no remaining Vanda Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Farmers & Merchants Investments Inc sold 37 Vanda Pharmaceuticals shares in Q3 2023, an estimated $244.
  • Farmers & Merchants Investments Inc first reported a position in Vanda Pharmaceuticals in Q3 2022 and held it in 4 quarters.
  • Farmers & Merchants Investments Inc's Vanda Pharmaceuticals position peaked at $273 in Q4 2022.
  • 179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2023.

Based on Farmers & Merchants Investments Inc's 13F filing for Q3 2023, filed 25 Oct 2023.